Based on clinicopathological characteristics and immunohistochemical tests, breast cancer has been classified into different pathological subtypes, in which patients who are estrogen receptor (ER) and progesterone receptor (PR) positive show an ideal response to endocrine therapy and a good prognosis (7). This evidence concerns the gene ESR1 and breast carcinoma.